Cassava Sciences, Inc.
SAVA
$2.73
$0.155.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 65.67% | -152.94% | -147.43% | -137.76% | -133.11% |
| Gross Profit | -65.67% | 152.94% | 147.43% | 137.76% | 133.11% |
| SG&A Expenses | 283.41% | 330.87% | 306.45% | 16.92% | 37.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.31% | 30.40% | 35.19% | 11.91% | 32.29% |
| Operating Income | -25.31% | -30.40% | -35.19% | -11.91% | -32.29% |
| Income Before Tax | 74.96% | 81.49% | 82.93% | 42.28% | -27.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 74.96% | 81.49% | 82.93% | 42.28% | -27.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.96% | 81.49% | 82.93% | 42.28% | -27.50% |
| EBIT | -25.31% | -30.40% | -35.19% | -11.91% | -32.29% |
| EBITDA | -26.06% | -31.19% | -35.84% | -12.02% | -32.53% |
| EPS Basic | 81.00% | 84.18% | 82.13% | 43.36% | -22.28% |
| Normalized Basic EPS | 88.87% | 83.28% | 82.24% | 43.48% | -22.14% |
| EPS Diluted | 37.55% | 39.88% | 35.71% | -6.28% | -22.53% |
| Normalized Diluted EPS | 88.25% | 82.65% | 81.58% | 42.76% | -22.14% |
| Average Basic Shares Outstanding | 10.47% | 7.85% | 5.50% | 3.94% | 4.30% |
| Average Diluted Shares Outstanding | 11.12% | 8.51% | 6.17% | 4.62% | 4.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
